• Delivering Innovative Research
    to the Therapy Analysis market
    Find out more
  • Identifying and commercializing
    first-in-class innovation in early stage development
    Find out more
  • Thought provoking insights
    covering hot topics and key industry issues
    Find out more
  • Providing specialty research and data
    to the devices and diagnostics industries
    Find out more

Meaningful, innovative and evidence-based analysis to help inform key decision making

Our goal is to be the business intelligence partner of choice for companies in the healthcare arena looking for meaningful, innovative and evidence-based analysis to inform their key decision making.

At GBI Research, we leverage extensive proprietary databases and employ novel data interrogation methodologies to generate new and meaningful analyses and insights.

Our content and coverage are informed by close collaboration with a global network of domain-specific external partners; this allows us to deliver novel, thought-provoking and idea-generating insights that clients would normally struggle to access.

Our in-house team of researchers and analysts – typically with MBAs, PhDs and MScs, as well as considerable healthcare industry experience is located across the UK, US and Asia Pacific.

The team provides expert and insightful commentary to support evidence-based analyses of established and emerging markets.

Find out more about GBI Research

Analyst Views

31 Aug 16
Do Expedited Drug Development Programs Do More Harm Than Go....
In this Analyst View, Fiona Chisholm, Analyst for GBI Research, discusses the effectivene.....
Read post
29 Jul 16
Respiratory Disorders Set to Benefit from Influx of Novel T....
In this Analyst View, Yasser Mushtaq, Senior Analyst for GBI Research, discusses the resp.....
Read post

White Papers

13 Jul 16
Introducing CBR Pharma Insights....
The latest CBR Pharma Insights white paper, Accelerating your Healthcare Insights, discus....
Read post
27 Oct 15
The Obesity Landscape: Obstacles to Current and Future Weig....
This white paper begins by examining the impact of the global obesity epidemic by conside....
Read post

Press Releases

11 Oct 16
Cardiovascular disease market set to grow very slowly to $1....
The cardiovascular disease market, which includes hypertension, dyslipidemia, and thrombo.....
Read post
06 Oct 16
Gastrointestinal drugs market to hit $48.4 billion by 2022 ....
The market size for gastrointestinal therapeutics is set to grow from $35.7 billion in 20.....
Read post